In this episode, we visit with Christopher Furmon who leads Vitro based in Colorado. Christopher doesn't come from a traditional biopharma track. Instead, he spent decades helping build the financial juggernaut Janus.
Vitro Biopharma has a goal to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market; and ultimately, to address well-established multi-billion-dollar commercial markets.
The team has over 30 years of drug discovery and development experience that has enabled them to identify and advance multiple product candidates from preclinical studies into clinical trials. Specifically, their extensive knowledge of immunology and inflammatory conditions informs their decision making to advance the scientific and clinical path to demonstrate proof-of-concept, with the goal of achieving an efficient timeframe and cost-effective budget. Visit them at www.vitrobiopharma.com
AvodahMed is an advanced technology company improving quality care for patients and healthcare providers. They provide a unique solution that embeds AI throughout live...
Hall Venture Partners is the venture fund sponsored by and investing alongside the Hall Family. The Halls are a 3rd generation family office that...
Katherine Hill Ritchie has extensive background running single family offices including a strong emphasis on sourcing alternative investments. Her most recent role involves both...
